Together, we can improve the lives of breast cancer patients everywhere

Leadership

Our founders are recognized leaders in the field of genomics. Their prominent roles at comprehensive cancer centers put Agendia in an excellent position to partner with the academic world.

Mark R. Straley

Kurt Becker

Brian Dow

William Audeh, MD, MS

Prof. Laura van ‘t Veer, PhD

Prof. Dr. René Bernards, PhD

Bastiaan Van Der Baan

Wendy Blosser

Roopom Banerjee

Board of Directors

PATRICK J. BALTHROP, SR CHAIRMAN
CHRISTOPH WAER SUPERVISORY BOARD MEMBER
LAURIE HEILMANN SUPERVISORY BOARD MEMBER
PETER STEIN SUPERVISORY BOARD MEMBER
FRANÇOIS FERRÉ SUPERVISORY BOARD MEMBER
ERIK ESVELD SUPERVISORY BOARD MEMBER

Where to next?

MammaPrint
BluePrint
Published Studies
Ongoing studies

IVDMIA = in vitro diagnostic multivariate index assay
Next-generation sequencing is a newer form of DNA sequencing technology. In addition to reducing the costs and time to sequence DNA, sequencing can be conducted with smaller samples.